Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Qianlan, Yao"'
Autor:
Changmin Yu, Xinhui Yuan, Qianlan Yao, Yuyin Xu, Xiaoyan Zhou, Xin Hu, Huijuan Yang, Huaying Wang, Xiaoli Zhu, Yulan Ren
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Objective The International Federation of Gynecology and Obstetrics (FIGO) 2023 staging system for endometrial cancer (EC) was released with incorporating histology, lympho-vascular space invasion, and molecular classification together. Our
Externí odkaz:
https://doaj.org/article/4ff451d58f1e4772a4aca7af304798ae
Autor:
Min Ren, Qianlan Yao, Longlong Bao, Zhiting Wang, Ran Wei, Qianming Bai, Bo Ping, Cai Chang, Yu Wang, Xiaoyan Zhou, Xiaoli Zhu
Publikováno v:
European Thyroid Journal, Vol 11, Iss 3, Pp 1-9 (2023)
Objective: The data regarding the mutation landscape in Chinese patients with thyroid cancer are limited. The diagnostic performance of thyroid nodul es by fine-needle aspiration (FNA) cytology needs optimization, especially in indeterminate nodules.
Externí odkaz:
https://doaj.org/article/daf6b149777b45f8bc447e9f4a9eac82
Autor:
Yupeng Zeng, Ran Wei, Longlong Bao, Tian Xue, Yulan Qin, Min Ren, Qianming Bai, Qianlan Yao, Chengli Yu, Chen Chen, Ping Wei, Baohua Yu, Junning Cao, Xiaoqiu Li, Qunling Zhang, Xiaoyan Zhou
Publikováno v:
American Journal of Surgical Pathology; Aug2024, Vol. 48 Issue 8, p919-929, 11p
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundEarly diagnosis of colorectal cancer could significantly improve the prognosis and reduce mortality. However, indeterminate diagnosis is often met in pathology diagnosis in biopsy samples. Abnormal expression of long non-coding RNA (lncRNA)
Externí odkaz:
https://doaj.org/article/8c2a4b21b10648189e433a72c7a811d4
Autor:
Xisheng Liu, Xiaole Meng, Xiao Peng, Qianlan Yao, Fangming Zhu, Zhongyi Ding, Hongze Sun, Xueni Liu, Dan Li, Ying Lu, Huamei Tang, Bin Li, Zhihai Peng
Publikováno v:
Cell Death and Disease, Vol 12, Iss 4, Pp 1-15 (2021)
Abstract Increasing evidence suggests that global downregulation of miRNA expression is a hallmark of human cancer, potentially due to defects in the miRNA processing machinery. In this study, we found that the protein expression of Argonaute 2 (AGO2
Externí odkaz:
https://doaj.org/article/313bc343c7e9480a9027b31545489a83
Autor:
Wei Jiang, Xueyan Ouyang, Chunjuan Jiang, Lina Yin, Qianlan Yao, Xuan Pei, Zhaodong Ji, Ming Li, Shaoli Song, Wentao Yang, Shenglin Huang, Huijuan Yang, Boer Shan
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 6, p 5091 (2023)
Peritoneal implantation and lymph node metastasis have different driving mechanisms in ovarian cancer. Elucidating the underlying mechanism of lymph node metastasis is important for treatment outcomes. A new cell line, FDOVL, was established from a m
Externí odkaz:
https://doaj.org/article/64d6a7e0122d4b40b38fc3bbea80b2f3
Autor:
Qianlan Yao, Yanhui Liu, Lihua Zhang, Lin Dong, Longlong Bao, Qianming Bai, Qian Cui, Jie Xu, Min Li, Jing Liu, Shannon Chuai, Jianming Ying, Zhihong Zhang, Xiaoyan Zhou
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectiveThe status of homologous recombination repair (HRR) gene mutations and their impact on the survival of patients with Chinese epithelial ovarian cancer (EOC) are still unclear. In this study, we retrospectively analyzed the mutations of HRR g
Externí odkaz:
https://doaj.org/article/e3b7b951aad4442bb8f4a3e96d40fc08
Publikováno v:
Diagnostic Pathology, Vol 15, Iss 1, Pp 1-9 (2020)
Abstract Background Uterine tumors resembling ovarian sex-cord tumors (UTROSCTs) are rare mesenchymal neoplasms predominantly arising in perimenopausal and postmenopausal women. UTROSCTs with growth regulation by estrogen in breast cancer 1 (GREB1)-r
Externí odkaz:
https://doaj.org/article/4ce5f3af28ab43fa8889e133c3c8eb8f
Autor:
Yifan Su, Qianlan Yao, Yuyin Xu, Chengli Yu, Jing Zhang, Qian Wang, Jiwei Li, Di Shi, Baohua Yu, Yupeng Zeng, Xiaoli Zhu, Qianming Bai, Xiaoyan Zhou
Publikováno v:
Frontiers in Genetics, Vol 12 (2021)
Background:Expert consensus on BRCA1/2 genetic testing and clinical application in Chinese breast cancer patients recommends that BRCA1/2 testing should be performed in those with clinical risk factors, such as an early onset, triple-negative breast
Externí odkaz:
https://doaj.org/article/eab916b4e8a84a7e8b8efaa8d1c1a3b6
Autor:
Qianlan Yao1, Qianming Bai1, Xin Zhang2, Gang Ji1, Heng Chang1, Xu Cai1, Lin Yu1, Jian Wang1, Xiaoli Zhu1, Xiaoyan Zhou1 xyzhou100@163.com
Publikováno v:
Archives of Pathology & Laboratory Medicine. Oct2022, Vol. 146 Issue 10, p1234-1242. 9p. 4 Color Photographs, 1 Diagram, 1 Chart.